2450-2451 / 2953
N0/N1 – non metastatic prostate cancer
•
Evidence unclear for concomitant RT to whole pelvis to treat
pelvic LN for N0/N+ - studies N0 with different dose and RT
techniques
•
Historically associated with high toxicity
•
Inadequate dose
•
N0 to N+ - detection and imaging utilised
•
N+ to N0 with neoadjuvant ADT= treat microscopic disease
•
No RCT has assessed the role of RT N+ M0 patients and none are
planned.